SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CELEGHINI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.059
AS - Asia 3.492
EU - Europa 1.853
SA - Sud America 620
AF - Africa 71
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 13.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.927
SG - Singapore 1.350
CN - Cina 852
BR - Brasile 495
VN - Vietnam 401
IT - Italia 327
DE - Germania 288
UA - Ucraina 284
TR - Turchia 255
HK - Hong Kong 248
PL - Polonia 230
GB - Regno Unito 200
FI - Finlandia 129
FR - Francia 99
RU - Federazione Russa 83
SE - Svezia 71
IN - India 69
CA - Canada 60
MX - Messico 53
ID - Indonesia 49
JP - Giappone 44
AR - Argentina 41
BD - Bangladesh 35
NL - Olanda 35
ES - Italia 31
ZA - Sudafrica 31
IQ - Iraq 30
EC - Ecuador 26
PK - Pakistan 26
SA - Arabia Saudita 19
CO - Colombia 16
BE - Belgio 14
UZ - Uzbekistan 14
VE - Venezuela 13
MY - Malesia 12
AT - Austria 11
PH - Filippine 11
AU - Australia 9
CL - Cile 9
IR - Iran 9
LT - Lituania 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 7
IL - Israele 7
NP - Nepal 7
AL - Albania 6
AZ - Azerbaigian 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
DZ - Algeria 5
KZ - Kazakistan 5
PY - Paraguay 5
RO - Romania 5
TH - Thailandia 5
BO - Bolivia 4
CR - Costa Rica 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BH - Bahrain 3
CY - Cipro 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
KR - Corea 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
AO - Angola 2
BG - Bulgaria 2
CH - Svizzera 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MD - Moldavia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BS - Bahamas 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
MM - Myanmar 1
Totale 13.099
Salva come PNG Salva come JPEG
Città #
Singapore 822
Woodbridge 820
Ashburn 770
Fairfield 712
Houston 380
San Jose 358
Jacksonville 332
Seattle 318
Chandler 306
Cambridge 305
Beijing 282
Santa Clara 258
Wilmington 246
Ann Arbor 245
Hong Kong 243
Warsaw 228
Izmir 138
Ferrara 129
Ho Chi Minh City 123
Los Angeles 108
Dallas 103
Nanjing 96
New York 89
Hanoi 84
Princeton 76
Boardman 64
Council Bluffs 63
Munich 61
Lauterbourg 60
Milan 49
Helsinki 48
Dearborn 41
San Diego 41
Tokyo 39
São Paulo 37
Jakarta 35
The Dalles 35
Nanchang 34
Shanghai 34
Columbus 33
Mexico City 32
Orem 30
Buffalo 28
London 27
Changsha 24
Shenyang 24
Bremen 23
Tianjin 23
Da Nang 22
Frankfurt am Main 22
Johannesburg 22
Manchester 21
Montreal 21
Turku 21
Chennai 20
Jinan 20
Denver 19
Mountain View 19
Chicago 18
Jiaxing 17
Haiphong 16
Moscow 16
Falls Church 15
Hebei 15
Stockholm 15
Brooklyn 14
Toronto 14
Bologna 13
Brussels 13
Dong Ket 13
Kunming 13
San Mateo 13
Zhengzhou 13
Biên Hòa 12
Boston 12
Hefei 12
Leawood 12
Poplar 12
Rio de Janeiro 12
San Francisco 12
Baghdad 11
Hải Dương 11
Quito 11
Amsterdam 10
Aprilia 10
Falkenstein 10
Phoenix 10
Redwood City 10
Washington 10
Ankara 9
Norwalk 9
Tappahannock 9
Tashkent 9
Auburn Hills 8
Brasília 8
Curitiba 8
Ottawa 8
Riyadh 8
Atlanta 7
Bắc Ninh 7
Totale 9.148
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 324
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 285
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 271
Neuronal dysfunction associated with cholesterol deregulation 265
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 250
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 237
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 224
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 223
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 221
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 214
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies 210
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 210
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 208
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 207
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 204
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 202
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 190
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 187
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 176
Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease 169
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells 164
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients 164
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 160
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line 158
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 156
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 155
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 151
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 151
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 150
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 146
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 146
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate 145
In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection 142
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells 142
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? 141
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 140
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 138
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 136
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 133
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 133
In vivo and in vitro modulatory effect of human immunodeficiency virus type (HIV-1) Tat protein on protein kinase C activity. 131
Pre-eclampsia affects procalcitonin production in placental tissue 120
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 119
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. 118
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 118
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells 109
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 107
null 105
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 103
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 100
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 99
null 98
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 98
MitoQ is able to modulate apoptosis and inflammation 98
null 97
null 94
null 92
null 90
null 90
null 89
null 89
null 89
null 89
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 89
null 88
null 88
null 88
null 86
null 86
null 86
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells 86
null 86
null 86
null 85
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 84
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development 84
Potential role of circulating microRNAs as early markers of preeclampsia 83
null 83
null 83
null 82
null 81
null 81
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 79
null 78
null 76
null 76
null 76
null 76
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 75
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 75
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival 72
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease 70
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 70
null 66
null 65
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia 64
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes 60
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 59
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs erythroid cells 59
Totale 12.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021393 0 0 0 0 0 0 0 0 0 169 141 83
2021/2022617 21 39 30 26 50 51 41 40 33 73 64 149
2022/2023758 77 43 26 100 122 113 48 44 95 10 34 46
2023/2024359 59 46 12 11 10 49 21 30 7 19 10 85
2024/20251.772 42 25 136 70 240 134 96 107 297 164 260 201
2025/20264.470 471 236 434 610 685 319 541 277 416 481 0 0
Totale 13.293